4 Healthcare Takeaways from Biden’s State of the Union Address

In his State of the Union address, President Biden highlighted several critical healthcare issues facing Americans, including reproductive rights, prescription drug costs, the Affordable Care Act, and women’s health research. He criticized states banning abortion and promised to restore Roe v. Wade if Congress supports it. Biden discussed proposals to cap insulin costs and negotiate…

Read More

Continuous PEG-Asparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL

A study published in the Journal of Clinical Oncology found that a continuous dosing schedule of PEG-asparaginase (PEGasp) in children with acute lymphoblastic leukemia (ALL) reduced hypersensitivity reactions and antibody formation compared to a noncontinuous schedule. The study included 818 patients aged 1-18, with 312 in the medium-risk arm. Results showed fewer hypersensitivity reactions in…

Read More

Everything You Need to Know About Suboxone

Suboxone is a medication used to treat opioid addiction by reducing cravings and withdrawal symptoms. It contains buprenorphine and naloxone, which work in the brain to alleviate symptoms without the same euphoric effects as opioids. Suboxone is commonly used in medication-assisted treatment programs to help individuals manage their addiction. However, there are potential side effects…

Read More

Headspace launches young adult mindfulness app Headspace XR

Headspace, a digital mental health company, has launched a new virtual reality app called Headspace XR aimed at helping users strengthen their mind-body connection through movement and breathwork. The app includes mood-boosting games, guided meditations, and techniques to reach a younger audience, especially Gen Z. Headspace plans to conduct a study to evaluate the app’s…

Read More

Biden Said State of the Union Is Strong and Made Clear His Campaign Is Off and Running

President Joe Biden delivered a State of the Union address focusing on accomplishments in health care, as well as discussing immigration, the economy, crime, job growth, infrastructure, and international conflicts. Biden aimed to counter his low approval ratings and draw contrasts between his policies and those of Trump and some Republicans, without mentioning Trump by…

Read More

Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Amylyx Pharmaceuticals announced that their ALS treatment, Relyvrio, failed to provide any benefit in a large clinical trial, leading to consideration of withdrawing the medicine. The FDA called for a meeting to discuss Eli Lilly’s Alzheimer’s drug, donanemab, despite successful trial results. President Biden’s proposal to expand Medicare price negotiation in his State of the…

Read More

February top picks: new beginnings

On February 1, the UK Foundation Programme Office announced changes to the specialised foundation programme recruitment, moving to a “preference informed allocation” system. This new algorithmically generated ranking system has raised concerns among academics, clinicians, and students about its impact on clinical academia. Medical student Marina Politis and colleagues argue that the changes will add…

Read More
error: Content is protected !!